IP Library › Granted Patent US 8,470,973
Granted Patent B2
US 8,470,973 · App. 13/218,050 · Granted Jun 25, 2013

Modular DNA-binding domains and methods of use

Inventors: Ulla Bonas (Halle, DE); Jens Boch (Halle, DE); Sebastian Schornack (Norwich, GB); Thomas Lahaye (Halle, DE)
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,470,973
App. No.
13/218,050
Granted
Jun 25, 2013
Kind
B2
Abstract

The present invention refers to methods for selectively recognizing a base pair in a DNA sequence by a polypeptide, to modified polypeptides which specifically recognize one or more base pairs in a DNA sequence and, to DNA which is modified so that it can be specifically recognized by a polypeptide and to uses of the polypeptide and DNA in specific DNA targeting as well as to methods of modulating expression of target genes in a cell.

Claims (8)

1. A method for modifying the genome of a cell, the method comprising introducing into the cell a nucleic acid molecule encoding a non-naturally occurring fusion protein comprising an artificial transcription activator-like (TAL) effector repeat domain of contiguous repeat units 33 to 35 amino acids in length and an endonuclease domain, wherein the repeat domain is engineered for recognition of a predetermined nucleotide sequence, and wherein the fusion protein recognizes the predetermined nucleotide sequence.

2. The method of claim 1 , wherein the cell is a eukaryotic cell.

3. The method of claim 1 , wherein the cell is an animal cell.

4. The method of claim 1 , wherein the cell is a mammalian cell.

5. The method of claim 1 , wherein the cell is a human cell.

6. The method of claim 1 , wherein the cell is a plant cell.

7. The method of claim 1 , wherein the cell is a prokaryotic cell.

8. The method of claim 1 , wherein the fusion protein introduces an endonucleolytic cleavage in a nucleic acid of the cell, whereby the genome of the cell is modified.

Priority Claims (2)
DE 10 2009 004 659 · Jan 12, 2009 · national
EP 09165328 · Jul 13, 2009 · regional
Continuity (5)
Continuation 13019526 · Feb 2, 2011
Continuation In Part 13016297 · Jan 28, 2011
Continuation PCTIB2010000154 · Jan 12, 2010
Provisional Application 61225043 · Jul 13, 2009
Related Publication 20120110685A1 · May 3, 2012